Phase 2 Chronic Fatigue Syndrome Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Myalgic EncephalomyelitisChronic Fatigue Syndrome
Weill Medical College of Cornell University95 enrolled1 locationNCT04542161
Not Yet Recruiting
Phase 2
A Study of Safety and Efficacy of STIR-101 in Participants Experiencing Symptoms of Long Covid
Chronic Fatigue Syndrome
STIR Pharma Ltd40 enrolled1 locationACTRN12625001372471
Recruiting
Phase 2
Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
National Center of Neurology and Psychiatry, Japan30 enrolled1 locationNCT06952413
Recruiting
Phase 2Phase 3
TRI-ME: Trimetazidine to treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A double-blind, randomised, placebo-controlled efficacy trial
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Deakin University126 enrolled1 locationACTRN12625000095460
Recruiting
Phase 2
Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation
Chronic Fatigue SyndromeCOVID-19, Long Haul
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland132 enrolled1 locationNCT05967052
Terminated
Phase 2
Mitochondrial agents in the treatment of chronic fatigue syndrome: a 20-week, open-label, intervention trial
Chronic Fatigue Syndrome
The University of Melbourne30 enrolled1 locationACTRN12616000567426